Concentration of IL-1β was significantly lower in the serum samples of BM-MSC-treated apneic rats than in MSC-untreated apneic animals, indicating that intravenously injected MSCs efficiently suppressed OSA-induced IL-1β-driven systemic inflammation [24]. This evidence concerns the gene IL1B and obstructive sleep apnea syndrome.